Edition:
United States

People: Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

171.28USD
28 Jul 2016
Change (% chg)

$0.60 (+0.35%)
Prev Close
$170.68
Open
$168.93
Day's High
$171.80
Day's Low
$166.51
Volume
5,192,503
Avg. Vol
2,869,361
52-wk High
$181.81
52-wk Low
$130.09

Baltimore, David 

Dr. David Baltimore, Ph.D., is an Independent Director of Amgen Inc. David Baltimore is President Emeritus and Robert Andrews Millikan Professor of Biology at the California Institute of Technology, or Caltech. He received the Nobel Prize in Medicine as a co-recipient in 1975. Dr. Baltimore has been a director of Regulus Therapeutics Inc., a biopharmaceutical company, since 2007, serving on its Compensation Committee and chairing its Nominating and Governance Committee, and is a member of its scientific advisory board. Dr. Baltimore has also been a member of the board of directors of Immune Design Corp. (formerly Vaccsys), a clinical-stage immunotherapy company, since 2008, chairing its Nominating and Governance Committee, and is a member of its scientific advisory board. He was a director of BB Biotech, AG, a Swiss investment company, from 1994 to March 2011 and served as a director of MedImmune, Inc., a privately-held antibody formulation company, from 2003 to 2007. In 2008, Dr. Baltimore became a founder of Calimmune, Inc., a privately-held clinical-stage gene therapy company, and served as Chairman of the board of directors until November 2015.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Bradway

16,097,700

David Meline

6,592,620

Madhavan Balachandran

4,986,140

Sean Harper

5,607,820

Anthony Hooper

6,414,730

Brian McNamee

--
As Of  30 Dec 2015